CCG Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,854
| Closed | -$208K | – | 129 |
|
|
2021
Q4 | $208K | Hold |
1,854
| – | – | 0.11% | 89 |
|
|
2021
Q3 | $233K | Hold |
1,854
| – | – | 0.13% | 88 |
|
|
2021
Q2 | $251K | Buy |
1,854
+122
| +7% | +$16.5K | 0.2% | 59 |
|
|
2021
Q1 | $235K | Hold |
1,732
| – | – | 0.23% | 58 |
|
|
2020
Q4 | $244K | Sell |
1,732
-484
| -22% | -$68.2K | 0.26% | 63 |
|
|
2020
Q3 | $247K | Sell |
2,216
-260
| -11% | -$29K | 0.23% | 44 |
|
|
2020
Q2 | $277K | Sell |
2,476
-447
| -15% | -$50K | 0.26% | 35 |
|
|
2020
Q1 | $226K | Sell |
2,923
-12
| -0.4% | -$928 | 0.22% | 52 |
|
|
2019
Q4 | $279K | Buy |
2,935
+243
| +9% | +$23.1K | 0.18% | 70 |
|
|
2019
Q3 | $205K | Buy |
+2,692
| New | +$205K | 0.14% | 82 |
|